NCT07522957 Comparison of Two Airway Devices (I-Gel and Air-Q) in Children Aged 1-10 Years During General Anesthesia
| NCT ID | NCT07522957 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ankara Etlik City Hospital |
| Condition | Anesthesia General |
| Study Type | OBSERVATIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-04 |
| Primary Completion | 2026-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 60 participants in total. It began in 2026-04 with a primary completion date of 2026-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to compare two commonly used airway devices (I-gel and Air-Q) in children aged 1-10 years undergoing general anesthesia for surgery. These devices help doctors keep the airway open and support breathing during the operation. The study will evaluate how well each device works, how easy they are to place, and whether they cause air to enter the stomach. Ultrasound will be used to safely check the position of the device and detect any air in the stomach. The results of this study may help improve the safety and effectiveness of airway management in children during anesthesia.
Eligibility Criteria
Inclusion Criteria: * Children aged 1-10 years * American Society of Anesthesiologists (ASA) physical status I-II * Scheduled for elective (non-emergency) surgery under general anesthesia * Planned use of a supraglottic airway device for airway management * Written informed consent obtained from a parent or legal guardian Exclusion Criteria: * History of conditions associated with increased risk of aspiration (e.g., gastroesophageal reflux) * Known or predicted difficult airway (e.g., Mallampati score ≥ 3) * Congenital or acquired abnormalities of the face, neck, or upper airway * Active upper respiratory tract infection * Presence of significant pulmonary disease (e.g., asthma, bronchopulmonary dysplasia, cystic fibrosis) * Body mass index above the 95th percentile for age (morbid obesity) * Emergency surgery * Previous complications related to supraglottic airway device use * Failure of device placement or need to switch to an alternative airway management technique * Refusal of participation by parent or legal guardian
Frequently Asked Questions
Who can join the NCT07522957 clinical trial?
This trial is open to participants of all sexes, aged 1 Year or older, up to 10 Years, studying Anesthesia General. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07522957 currently recruiting?
Yes, NCT07522957 is actively recruiting participants. Visit ClinicalTrials.gov or contact Ankara Etlik City Hospital to inquire about joining.
Where is the NCT07522957 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT07522957 clinical trial?
NCT07522957 is sponsored by Ankara Etlik City Hospital. The trial plans to enroll 60 participants.